MCRB: Seres Therapeutics Inc
MCRB exchange rate has changed by 3.53% for today. During the day, the instrument was traded at a low of 8.6800 and at a high of 8.9200.
Follow Seres Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MCRB News
- Seres Therapeutics schedules 2026 annual meeting for June 9
- Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript
- Seres stock falls after pausing Phase 2 study and cutting workforce by 30%
- Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'
- Seres Therapeutics publishes new insights on VOWST mechanism
- 3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround
- Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director
- Seres to present new data on SER-155 bloodstream infection study
- Seres Therapeutics announces workforce reduction to extend cash runway
- Factbox-More companies adopt co-CEO structure
- Canaccord Genuity raises Seres Therapeutics stock price target to $22 on FDA hopes
- Seres Therapeutics advances SER-155 protocol after FDA feedback
- Factbox-More companies adopt co-CEO structure
- All You Need to Know About Seres Therapeutics (MCRB) Rating Upgrade to Buy
- Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - CDT Equity (NASDAQ:CDT), Acrivon Therapeutics (NASDAQ:ACRV)
- Seres Therapeutics (MCRB)'s Technical Outlook is Bright After Key Golden Cross
- Seres (MCRB) Q2 Loss Narrows 34%
- Seres Therapeutics August 2025 slides: SER-155 shows 77% infection reduction
- Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough
Frequently Asked Questions
What is MCRB stock price today?
Seres Therapeutics Inc stock is priced at 8.8000 today. It trades within 8.6800 - 8.9200, yesterday's close was 8.5000, and trading volume reached 14. The live price chart of MCRB shows these updates.
Does Seres Therapeutics Inc stock pay dividends?
Seres Therapeutics Inc is currently valued at 8.8000. Dividend policy depends on the company, while investors also watch 6.93% and USD. View the chart live to track MCRB movements.
How to buy MCRB stock?
You can buy Seres Therapeutics Inc shares at the current price of 8.8000. Orders are usually placed near 8.8000 or 8.8030, while 14 and 1.38% show market activity. Follow MCRB updates on the live chart today.
How to invest into MCRB stock?
Investing in Seres Therapeutics Inc involves considering the yearly range 7.8950 - 9.6000 and current price 8.8000. Many compare -0.94% and 6.93% before placing orders at 8.8000 or 8.8030. Explore the MCRB price chart live with daily changes.
What are Seres Therapeutics Inc stock highest prices?
The highest price of Seres Therapeutics Inc in the past year was 9.6000. Within 7.8950 - 9.6000, the stock fluctuated notably, and comparing with 8.5000 helps spot resistance levels. Track Seres Therapeutics Inc performance using the live chart.
What are Seres Therapeutics Inc stock lowest prices?
The lowest price of Seres Therapeutics Inc (MCRB) over the year was 7.8950. Comparing it with the current 8.8000 and 7.8950 - 9.6000 shows potential long-term entry points. Watch MCRB moves on the chart live for more details.
When did MCRB stock split?
Seres Therapeutics Inc has gone through stock splits historically. These changes are visible in , 8.5000, and 6.93% after corporate actions.
- Previous Close
- 8.5000
- Open
- 8.6800
- Bid
- 8.8000
- Ask
- 8.8030
- Low
- 8.6800
- High
- 8.9200
- Volume
- 14
- Daily Change
- 3.53%
- Month Change
- -0.94%
- 6 Months Change
- 6.93%
- Year Change
- 6.93%
- Act
- 1.925 M
- Fcst
- 0.705 M
- Prev
- -0.913 M
- Act
- 0.806 M
- Fcst
- 0.076 M
- Prev
- -1.727 M
- Act
- Fcst
- Prev
- 4.817%